# US 2019/0169678 A1 · Reagents and methods for the analysis of linked nucleic acids > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2019/0169678 A1 - Document ID: US20190169678A1 - Status: Published application - Kind: A1 - Application number: 16/277,794 - Filed: 2019-02-15 - Published: 2019-06-06 - Earliest claimed: 2016-12-23 - Assignees: CS Genetics Limited - Applicants: CS Genetics Limited - Inventors: Lucas Brandon Edelman - Web page: https://patentgrep.com/patent/US20190169678A1 ## CPC - C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) - C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection - C12Q 1/6827: for detection of mutation or polymorphism - C12Q 1/6832: Enhancement of hybridisation reaction - C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase - C12Q 1/6869: Methods for sequencing - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract Reagents and methods for the analysis of nucleic acids (e.g. genomic DNA) of circulating microparticles (i.e. microparticles originating from blood) are provided. The methods comprise linking at least two fragments of a target nucleic acid of a circulating microparticle to produce a set of at least two linked fragments of the target nucleic acid. In the methods, fragments of a target nucleic acid may be linked by techniques such as barcoding, partitioning, ligation and/or separate sequencing. The sequencing of a set of linked fragments provides a set of informatically linked sequence reads corresponding to the sequences of fragments from a single microparticle. ## Claims ### Claim 1 A method of analysing a sample comprising a cell-free circulating microparticle, wherein the cell-free circulating microparticle contains at least two fragments of genomic DNA, and wherein the method comprises: (a) linking at least two of the at least two fragments of genomic DNA to produce a set of at least two linked fragments of genomic DNA; and (b) measuring 5-methylcytosine in each of the linked fragments in the set to produce at least two linked measurements of 5-methylcytosine. ### Claim 2 (depends on 1) The method of claim 1, wherein step (b) comprises an enrichment process to enrich for fragments of genomic DNA containing 5-methylcytosine. ### Claim 3 (depends on 1) The method of claim 1, wherein step (b) comprises a bisulfite conversion process. ### Claim 4 (depends on 1) The method of claim 1, wherein step (b) comprises a nucleic acid sequencing process. ### Claim 5 (depends on 1) The method of claim 1, wherein at least 3, at least 4, at least 5, at least 10, at least 50, at least 100, at least 500, at least 1000, at least 5000, at least 10,000, at least 100,000, or at least 1,000,000 fragments of genomic DNA of the cell-free circulating microparticle are linked to produce at least 3, at least 4, at least 5, at least 10, at least 50, at least 100, at least 500, at least 1000, at least 5000, at least 10,000, at least 100,000, or at least 1,000,000 linked measurements of 5-methylcytosine. ### Claim 6 (depends on 1) The method of claim 1, wherein the sample comprises first and second cell-free circulating microparticles, wherein each cell-free circulating microparticle contains at least two fragments of genomic DNA, and wherein the method comprises performing step (a) to produce a first set of linked fragments of genomic DNA for the first cell-free circulating microparticle and a second set of linked fragments of genomic DNA for the second cell-free circulating microparticle, and performing step (b) to produce a first set of linked measurements of 5-methylcytosine for the first cell-free circulating microparticle and a second set of linked measurements of 5-methylcytosine for the second cell-free circulating microparticle. ### Claim 7 (depends on 1) The method of claim 1, wherein the sample comprises n cell-free circulating microparticles, wherein each cell-free circulating microparticle contains at least two fragments of genomic DNA, and wherein the method comprises performing step (a) to produce n sets of linked fragments of genomic DNA, one set for each of the n cell-free circulating microparticles, and performing step (b) to produce n sets of linked measurements of 5-methylcytosine, one for each of the n cell-free circulating microparticles. ### Claim 8 (depends on 7) The method of claim 7, wherein n is at least 3, at least 5, at least 10, at least 50, at least 100, at least 1000, at least 10,000, at least 100,000, at least 1,000,000, at least 10,000,000, or at least 100,000,000 cell-free circulating microparticles. ### Claim 9 (depends on 6) The method of claim 6, wherein prior to step (a), the method further comprises the step of partitioning the sample into at least two different reaction volumes. ### Claim 10 (depends on 1) The method of claim 1, wherein the method comprises: (a) appending the at least two fragments of genomic DNA of the cell-free circulating microparticle to a barcode sequence to produce a set of linked fragments of genomic DNA; and (b) measuring 5-methylcytosine in each of the linked fragments in the set to produce at least two linked measurements of 5-methylcytosine, wherein the at least two linked measurements of 5-methylcytosine are linked by the barcode sequence. ### Claim 11 (depends on 10) The method of claim 10, wherein prior to the step of appending the at least two fragments of genomic DNA of the cell-free circulating microparticle to a barcode sequence, the method comprises appending a coupling sequence to each of the fragments of genomic DNA of the cell-free circulating microparticle, wherein the coupling sequences are then appended to the barcode sequence to produce the set of linked fragments of genomic DNA. ### Claim 12 (depends on 10) The method of claim 10, wherein the sample comprises first and second cell-free circulating microparticles, wherein each cell-free circulating microparticle contains at least two fragments of genomic DNA, and wherein the method comprises performing step (a) to produce a first set of linked fragments of genomic DNA for the first cell-free circulating microparticle and a second set of linked fragments of genomic DNA for the second cell-free circulating microparticle, and performing step (b) to produce a first set of linked measurements of 5-methylcytosine for the first cell-free circulating microparticle and a second set of linked measurements of 5-methylcytosine for the second cell-free circulating microparticle, wherein the at least two linked measurements of 5-methylcytosine for the first cell-free circulating microparticle are linked by a different barcode sequence to the at least two linked measurements of 5-methylcytosine of the second cell-free circulating microparticle. ### Claim 13 (depends on 12) The method of claim 12, wherein prior to the step of appending, the method further comprises the step of partitioning the sample into at least two different reaction volumes. ### Claim 14 (depends on 1) The method of claim 1, wherein the method comprises: (a) appending each of the at least two fragments of genomic DNA of the cell-free circulating microparticle to a different barcode sequence of a set of barcode sequences to produce a set of linked fragments of genomic DNA; and (b) measuring 5-methylcytosine in each of the linked fragments in the set to produce at least two linked measurements of 5-methylcytosine, wherein the at least two linked measurements of 5-methylcytosine are linked by the set of barcode sequences. ### Claim 15 (depends on 14) The method of claim 14, wherein prior to the step of appending each of the at least two fragments of genomic DNA of the cell-free circulating microparticle to a different barcode sequence, the method comprises appending a coupling sequence to each of the fragments of genomic DNA of the cell-free circulating microparticle, wherein each of the at least two fragments of genomic DNA of the cell-free circulating microparticle is appended to a different barcode sequence of the set of barcode sequences by its coupling sequence. ### Claim 16 (depends on 14) The method of claim 14, wherein the sample comprises first and second cell-free circulating microparticles, wherein each cell-free circulating microparticle contains at least two fragments of genomic DNA, and wherein the method comprises performing step (a) to produce a first set of linked fragments of genomic DNA for the first cell-free circulating microparticle and a second set of linked fragments of genomic DNA for the second cell-free circulating microparticle, and performing step (b) to produce a first set of linked measurements of 5-methylcytosine for the first cell-free circulating microparticle and a second set of linked measurements of 5-methylcytosine for the second cell-free circulating microparticle, wherein the first set of linked measurements of 5-methylcytosine are linked by a different set of barcode sequences to the second set of linked measurements of 5-methylcytosine. ### Claim 17 (depends on 16) The method of claim 16, wherein prior to the step of appending, the method further comprises the step of partitioning the sample into at least two different reaction volumes.